Comparison of tocilizumab as monotherapy or with add-on disease-modifying antirheumatic drugs in patients with rheumatoid arthritis and inadequate responses to previous treatments: an open-label study close to clinical practice.

Bykerk, Vivian P; Östör, Andrew J K; Alvaro-Gracia, José; Pavelka, Karel; Román Ivorra, José Andrés; Graninger, Winfried; Bensen, William; Nurmohamed, Michael T; Krause, Andreas; Bernasconi, Corrado; Aassi, Maher; Sibilia, Jean

Bykerk, Vivian P; Östör, Andrew J K; Alvaro-Gracia, José; Pavelka, Karel; Román Ivorra, José Andrés; Graninger, Winfried; Bensen, William; Nurmohamed, Michael T; Krause, Andreas; Bernasconi, Corrado; Aassi, Maher; Sibilia, Jean.

Affiliation

Bykerk VP; Inflammatory Arthritis Center, Hospital for Special Surgery, 535 East 70th Street, New York, NY, 10021, USA, bykerkv@hss.edu.

Clin Rheumatol ; 34(3): 563-71, 2015 Mar.

Article in En | MEDLINE | ID: mdl-25604316

Subject(s)

Antibodies, Monoclonal, Humanized/therapeutic use; Antirheumatic Agents/therapeutic use; Arthritis, Rheumatoid/drug therapy; Adult; Aged; Drug Therapy, Combination; Female; Humans; Male; Middle Aged; Treatment Outcome

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Arthritis, Rheumatoid / Antirheumatic Agents / Antibodies, Monoclonal, Humanized Limits: Adult / Aged / Female / Humans / Male / Middle aged Language: En Journal: Clin Rheumatol Year: 2015 Document type: Article Country of publication: Germany

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google